Avance Medical ^Company

Avance Medical is the first company to develop fully automated systems to produce autologous bio-regenerative fibrin. They process the patient’s own blood during a surgical procedure in the operating room to produce fibrin rich in clotting factors to stop bleeding. The fibrin also has anti-microbial properties especially effective against superbugs like MRSA being the major culprit for hospital-acquired infections. Further, the fibrin contains growth factors vital for regenerating connective tissues and facilitate wound homeostasis and healing. Avance is conducting a number of studies showing promising results in achieving these objectives.